Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 1
This trial looked at atovaquone with . It was for people with that had spread into the nearby tissue.
This trial was supported by Cancer Research UK. It was open for people to join between 2020 and 2022. The team analysed the results in 2024.
Recruitment start: 25 February 2021
Recruitment end: 14 December 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Geoff Higgins
Cancer Research UK
University of Oxford
MRC Oxford Institute for Radiation Oncology
Cancer Research UK Oxford Centre
Oncology Clinical Trials Office (OCTO) Oxford
Oxford Clinical Trials Research Unit (OCTRU)
This is Cancer Research UK trial number CRUK/18/015.
Last reviewed: 03 Apr 2025
CRUK internal database number: 16445
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
